Arabic Arabic English English French French German German

Circle Line: Laronde’s “Endless” RNA Draws $440M from Investors

Laronde’s Endless RNA (eRNA) is a versatile synthetic RNA platform designed to instruct cells to express a desired therapeutic protein inside the body. Because eRNA has no free ends, it is not recognized by the immune system and is stable, enabling a longer duration of protein expression than linear RNA. “We’re talking about weeks to months,” Laronde CEO Diego Miralles, MD, told GEN Edge. . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

The post Circle Line: Laronde’s “Endless” RNA Draws $440M from Investors appeared first on GEN – Genetic Engineering and Biotechnology News.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

White blood cells that can help destroy malignant tumors

Next Post

Men may sleep worse on nights during the first half of the lunar cycle

Related Posts